SWOG clinical trial number
SWOG-9519
Evaluation of Tomudex in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Closed
Phase
Accrual
68%
Published
Abbreviated Title
Evaluation of Tomudex in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Activated
06/15/1996
Closed
11/01/1997
Research committees
Head and Neck Cancer
Publication Information Expand/Collapse
1999
Evaluation of tomudex in patient with recurrent or metastatic squamous cell carcinoma of the head and neck: A Southwest Oncology Group study.